Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial

Peters, S., Letovanec, I., Mauer, M. et al. (15 more authors) (2023) Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial. Lung Cancer, 175. pp. 141-151. ISSN 0169-5002

Abstract

Metadata

Item Type: Article
Authors/Creators:
  • Peters, S.
  • Letovanec, I.
  • Mauer, M.
  • Dafni, U.
  • Ejedepang, D.
  • Biernat, W.
  • Bubendorf, L.
  • Warth, A.
  • Pokharel, S.
  • Reinmuth, N.
  • Majem Tarruella, M.
  • Casas-Martin, J.
  • Tsourti, Z.
  • Marti, N.
  • Kammler, R.
  • Danson, S. ORCID logo https://orcid.org/0000-0002-3593-2890
  • O'Brien, M.
  • Stahel, R.A.
Copyright, Publisher and Additional Information:

© 2022 Elsevier B.V. This is an author produced version of a paper subsequently published in Lung Cancer. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Keywords: Denosumab; NSCLC; RANK; RANKL
Dates:
  • Published: January 2023
  • Published (online): 13 December 2022
  • Accepted: 10 December 2022
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > The Medical School (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology and Metabolism (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 24 Jan 2023 16:12
Last Modified: 13 Dec 2023 01:13
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: 10.1016/j.lungcan.2022.12.004
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics